• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
An Evaluation of the ASTar Automated Antimicrobial Testing System for Gram-Negative Bacteria in Positive Blood Cultures.AStar自动抗菌检测系统对阳性血培养物中革兰氏阴性菌的评估
Antibiotics (Basel). 2025 Mar 1;14(3):249. doi: 10.3390/antibiotics14030249.
2
Performance of a System for Rapid Phenotypic Antimicrobial Susceptibility Testing of Gram-Negative Bacteria Directly from Positive Blood Culture Bottles.直接从阳性血培养瓶中快速进行革兰氏阴性菌表型抗菌药物敏感性测试的系统性能。
J Clin Microbiol. 2023 Mar 23;61(3):e0152522. doi: 10.1128/jcm.01525-22. Epub 2023 Feb 28.
3
Rapid phenotypic antimicrobial susceptibility testing of Gram-negative rods directly from positive blood cultures using the novel Q-linea ASTar system.利用新型 Q-linea ASTar 系统直接从阳性血培养物中快速表型抗微生物药物敏感性测试革兰氏阴性杆菌。
J Clin Microbiol. 2023 Nov 21;61(11):e0054923. doi: 10.1128/jcm.00549-23. Epub 2023 Oct 11.
4
Evaluation of an automated rapid phenotypic antimicrobial susceptibility testing (ASTar, Q-linea AB) applied directly on blood cultures bottles positive for Gram-negative pathogens.对直接应用于革兰氏阴性病原体呈阳性的血培养瓶的自动化快速表型抗菌药物敏感性试验(ASTar,Q-linea AB)的评估。
New Microbiol. 2024 May;47(1):107-110.
5
Rapid determination of antimicrobial susceptibility of Gram-negative bacteria from clinical blood cultures using a scattered light-integrated collection device.利用散射光集成收集装置快速测定临床血培养中革兰氏阴性菌的药敏性。
J Med Microbiol. 2024 Feb;73(2). doi: 10.1099/jmm.0.001812.
6
Improving Turnaround Times for Routine Antimicrobial Sensitivity Testing Following European Committee on Antimicrobial Susceptibility Testing Methodology in Patients with Bacteraemia.依据欧洲抗菌药物敏感性试验委员会方法,改善菌血症患者常规抗菌药物敏感性试验的周转时间
Antibiotics (Basel). 2024 Nov 17;13(11):1094. doi: 10.3390/antibiotics13111094.
7
Evaluation of three protocols for direct susceptibility testing for Gram-negative rods from flagged positive blood culture bottles.评估三种方案对阳性血培养瓶中革兰氏阴性杆菌直接药敏试验的效果。
Microbiol Spectr. 2024 Apr 2;12(4):e0308123. doi: 10.1128/spectrum.03081-23. Epub 2024 Mar 6.
8
Impact of reporting rapid susceptibility results in Gram negative bloodstream infections: a real world prospective study.报告革兰阴性菌血流感染快速药敏结果的影响:一项真实世界前瞻性研究。
Eur J Clin Microbiol Infect Dis. 2025 Apr;44(4):847-853. doi: 10.1007/s10096-025-05046-3. Epub 2025 Jan 25.
9
Evaluation of the Speed, Accuracy and Precision of the QuickMIC Rapid Antibiotic Susceptibility Testing Assay With Gram-Negative Bacteria in a Clinical Setting.在临床环境中评估快速 MIC 快速抗生素药敏检测试剂盒对革兰氏阴性菌的速度、准确性和精密度。
Front Cell Infect Microbiol. 2022 Mar 23;12:758262. doi: 10.3389/fcimb.2022.758262. eCollection 2022.
10
Rapid antimicrobial susceptibility testing on positive blood cultures through an innovative light scattering technology: performances and turnaround time evaluation.创新的光散射技术对阳性血培养物进行快速抗菌药物敏感性检测:性能和周转时间评估。
BMC Infect Dis. 2019 Nov 21;19(1):989. doi: 10.1186/s12879-019-4623-x.

本文引用的文献

1
Rapid Detection of Carbapenemases Using NG-Test CARBA 5 in Positive Blood Cultures: A Diagnostic Test Study.在阳性血培养物中使用NG-Test CARBA 5快速检测碳青霉烯酶:一项诊断试验研究
Antibiotics (Basel). 2024 Nov 20;13(11):1105. doi: 10.3390/antibiotics13111105.
2
Verification of the Vitek Reveal System for Direct Antimicrobial Susceptibility Testing in Gram-Negative Positive Blood Cultures.Vitek Reveal系统用于革兰氏阴性和阳性血培养直接药敏试验的验证
Antibiotics (Basel). 2024 Nov 7;13(11):1058. doi: 10.3390/antibiotics13111058.
3
Evaluation of the QIAstat-Dx BCID GN and GPF kits for direct identification and antimicrobial resistance prediction from blood culture bottles.评估QIAstat-Dx BCID GN和GPF试剂盒用于从血培养瓶中直接鉴定和预测抗菌药物耐药性。
J Clin Microbiol. 2024 Dec 11;62(12):e0116924. doi: 10.1128/jcm.01169-24. Epub 2024 Nov 6.
4
Getting Up to Speed: Rapid Pathogen and Antimicrobial Resistance Diagnostics in Sepsis.紧跟前沿:脓毒症中快速病原体及抗菌药物耐药性诊断
Microorganisms. 2024 Sep 3;12(9):1824. doi: 10.3390/microorganisms12091824.
5
A multicenter evaluation of a novel microfluidic rapid AST assay for Gram-negative bloodstream infections.一种新型微流控快速 AST 检测法对革兰氏阴性菌血流感染的多中心评估
J Clin Microbiol. 2024 Oct 16;62(10):e0045824. doi: 10.1128/jcm.00458-24. Epub 2024 Sep 26.
6
Evaluating the impact of rapid antimicrobial susceptibility testing for bloodstream infections: a review of actionability, antibiotic use and patient outcome metrics.评估血流感染快速抗菌药物敏感性检测的影响:对可操作性、抗生素使用和患者转归指标的综述。
J Antimicrob Chemother. 2024 Sep 19;79(Supplement_1):i13-i25. doi: 10.1093/jac/dkae282.
7
Early antibiotic de-escalation in patients with severe infections due to bloodstream infection by enterobacterales: A post hoc analysis of a prospective multicentre cohort.严重血流感染肠杆菌科所致感染患者的早期抗生素降阶梯治疗:一项前瞻性多中心队列的事后分析。
Int J Antimicrob Agents. 2024 Nov;64(5):107317. doi: 10.1016/j.ijantimicag.2024.107317. Epub 2024 Sep 2.
8
The Impact of Reporting the Same-Day Identification and Antibiotic Susceptibility Test Results on the Treatment of Bloodstream Infections.报告当日鉴定和抗生素敏感性试验结果对血流感染治疗的影响
Infect Dis Clin Microbiol. 2024 Jun 28;6(2):123-132. doi: 10.36519/idcm.2024.334. eCollection 2024 Jun.
9
Mortality impact of further delays in active targeted antibiotic therapy in bacteraemic patients that did not receive initial active empiric treatment: Results from the prospective, multicentre cohort PROBAC.未接受初始积极经验性治疗的菌血症患者进一步延迟积极靶向抗生素治疗的死亡率影响:来自前瞻性、多中心队列 PROBAC 的结果。
Int J Infect Dis. 2024 Aug;145:107072. doi: 10.1016/j.ijid.2024.107072. Epub 2024 May 1.
10
Evaluation of an automated rapid phenotypic antimicrobial susceptibility testing (ASTar, Q-linea AB) applied directly on blood cultures bottles positive for Gram-negative pathogens.对直接应用于革兰氏阴性病原体呈阳性的血培养瓶的自动化快速表型抗菌药物敏感性试验(ASTar,Q-linea AB)的评估。
New Microbiol. 2024 May;47(1):107-110.

AStar自动抗菌检测系统对阳性血培养物中革兰氏阴性菌的评估

An Evaluation of the ASTar Automated Antimicrobial Testing System for Gram-Negative Bacteria in Positive Blood Cultures.

作者信息

Coulson Hannah, Ivin Angelo, Day Kathryn M, Fenwick Danielle J C, Marrs Emma C L, Mpwilu Patrick, Perry John D

机构信息

Microbiology Department, Freeman Hospital, Newcastle upon Tyne NE7 7DN, UK.

出版信息

Antibiotics (Basel). 2025 Mar 1;14(3):249. doi: 10.3390/antibiotics14030249.

DOI:10.3390/antibiotics14030249
PMID:40149060
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11939750/
Abstract

: Prompt administration of optimal antibiotic therapy is essential in the management of bacteraemia to reduce morbidity and mortality and to facilitate antibiotic stewardship. To identify the most effective therapy, rapid and accurate antimicrobial susceptibility testing (AST) is essential. ASTar is an automated AST system that delivers minimum inhibitory concentrations (MICs) for 23 antimicrobials and is designed for testing Gram-negative bacteria directly from positive blood cultures, with results available after 6 h. : The ASTar system was evaluated with 64 positive blood cultures from patients with bacteraemia and 56 simulated blood cultures inoculated with a range of antibiotic-resistant isolates. The ASTar results for 12 antibiotics commonly used in our hospitals were compared with the results derived from three different methods of disc susceptibility testing and MICs determined by broth microdilution (BMD). : For 121 isolates of Gram-negative bacteria, ASTar showed an average essential agreement of 87.2% and an average categorical agreement of 94%, when compared with BMD. Very major errors (false susceptibility) and major errors (false resistance) were associated with 0.9% and 3.4% of results, respectively. The results were at least as accurate as those obtained from EUCAST disc susceptibility methods (both rapid and overnight methods). : The ASTar system is an effective method for delivering accurate and rapid (6 h) AST results for Gram-negative bacteria by the direct testing of positive blood cultures.

摘要

及时给予最佳抗生素治疗对于菌血症的管理至关重要,可降低发病率和死亡率,并促进抗生素管理。为了确定最有效的治疗方法,快速准确的抗菌药物敏感性试验(AST)必不可少。ASTar是一种自动化AST系统,可提供23种抗菌药物的最低抑菌浓度(MIC),专为直接从阳性血培养物中检测革兰氏阴性菌而设计,6小时后可获得结果。:使用来自菌血症患者的64份阳性血培养物和接种了一系列耐药菌株的56份模拟血培养物对ASTar系统进行了评估。将我院常用的12种抗生素的ASTar结果与三种不同纸片药敏试验方法以及肉汤微量稀释法(BMD)测定的MIC结果进行了比较。:对于121株革兰氏阴性菌,与BMD相比,ASTar显示平均基本一致率为87.2%,平均分类一致率为94%。极重大错误(假敏感)和重大错误(假耐药)分别与0.9%和3.4%的结果相关。结果至少与从EUCAST纸片药敏试验方法(快速和过夜方法)获得的结果一样准确。:ASTar系统是一种通过直接检测阳性血培养物为革兰氏阴性菌提供准确快速(6小时)AST结果的有效方法。